CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART) Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial Good response to tolvaptan shortens hospitalization in patients with congestive heart failure Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

Clinical Trial2018 Jun 12;71(23):2628-2639.

JOURNAL:J Am Coll Cardiol. Article Link

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

Kosiborod M, Lam CSP, CVD-REAL Investigators and Study Group. Keywords: SGLT-2 inhibitor; death; diabetes mellitus; heart failure; observational studies; sodium glucose cotransporter-2 inhibitors

FULL TEXT PDF